ArcelorMittal S.A.: ArcelorMittal announces publication of its second quarter 2024 sell-side analyst consensus figures
July 23, 2024 11:04 ET
|
ArcelorMittal S.A.
23 July 2024, 16:00 CET ArcelorMittal (‘the Company’) today announces the publication of its second quarter 2024 sell-side analyst consensus figures. The consensus figures are based on analysts’...
21Shares Expands its US Product Lineup with the Launch of the 21Shares Core Ethereum ETF (CETH)
July 23, 2024 09:30 ET
|
21Shares
CETH builds on the Company’s mission to make crypto assets more accessible, straightforward for investors, and serves as a testament to the asset class’s global momentumNEW YORK, July 23, 2024 –...
Kuntarahoitus laskee liikkeeseen 100 miljoonan euron lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa
July 22, 2024 03:00 ET
|
Kuntarahoitus Oyj
Kuntarahoitus OyjPörssitiedote22.07.2024 klo 10.00 Kuntarahoitus laskee liikkeeseen 100 miljoonan euron lisäyksen viitelainaan osana joukkovelkakirjalainaohjelmaa Kuntarahoitus Oyj laskee 23.07.2024...
Municipality Finance issues a EUR 100 million tap under its MTN programme
July 22, 2024 03:00 ET
|
Municipality Finance Plc
Municipality Finance PlcStock exchange release 22 July 2024 at 10:00 am (EEST) Municipality Finance issues a EUR 100 million tap under its MTN programme On 23 July 2024 Municipality Finance Plc...
Addex’s Partner Discontinues ADX71149 development in Epilepsy
July 22, 2024 01:00 ET
|
Addex Therapeutics
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio...
Einladung – Ascom Halbjahresmedienkonferenz 2024
July 22, 2024 01:00 ET
|
Ascom Holding AG
Sehr geehrte Damen und Herren Wir freuen uns, Sie zur Medien- und Analystenkonferenz anlässlich der Halbjahresresultate 2024 der Ascom Holding AG einzuladen. Sie haben zwei...
Invitation – Ascom Half-Year Results Conference 2024
July 22, 2024 01:00 ET
|
Ascom Holding AG
Ladies and Gentlemen, We cordially invite you to the online Half-Year Results Conference 2024 of Ascom Holding AG. There are two ways to participate in our...
EINLADUNG ZUR MEDIENKONFERENZ 14. August 2024, 11:00 Uhr
July 18, 2024 12:00 ET
|
Schweiter Technologies
EINLADUNG ZUR MEDIENKONFERENZ 14. August 2024, 11:00 Uhr Steinhausen, 18. Juli 2024 – Wir laden Sie herzlich zur Medienkonferenz für Investoren, Analysten und Medien ein. Neben Informationen...
Invitation to Idorsia's Half Year 2024 Financial Reporting webcast and conference call
July 18, 2024 11:45 ET
|
Idorsia Pharmaceuticals Ltd
Idorsia will publish its Half Year 2024 Financial Reporting on Thursday July 25, 2024, at 07:00 CEST. An investor conference call and webcast will be held to discuss the results on the same day. ...
New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
July 18, 2024 07:20 ET
|
F. Hoffmann-La Roche Ltd
Two-year Phase III data presented at ASRS 2024 show Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema (DME) and diabetic retinopathy (DR)Safety data were...